MYOCD and sarcoma: Similarly, fusions involving driver genes largely or exclusively restricted to sarcoma (e.g. KMT2A::YAP1 in case 9) are readily detectable, as are the more sarcoma-specific copy number targets (e.g. COPS3 in case 17 and MYOCD in case 13).